2[3]DERELLE J,BERTOLO H E,MARCHAL F,et al.Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus domasealfa[J].Arch Pediatr,1998,5(4):517-522.
3[4]KUPCZYK M,KUNA P.Mucolytics in acute and chronic respiratory tract disorders.Ⅰ.Pathophysiology and mechanisms of action[J].Pol Merkuriusz Lek,2002,12(69):245-247.
4[5]KUPCZYK M,KUNA P.Mucolytics in acute and chronic respiratory tract disorders.Ⅱ.Uses for treatment and antioxidant properties [J].Pol Merkuriusz Lek,2002,12(69):248-252.
5[7]AIBARA M,DOBASHI K,AKIYAMA M,et al .Effects of Nacetylcysteine and ambroxol on the production of IL-12 and i1-10in human alveolar macrophages[J].Respiration,2000,67(6):662-671.
6[8]GILLISEEN A,BARTLING A,SCHOESN S,et al.Antioxidant function of ambroxol in mononuclear and polymorph on nuclear cells in vitro[J].Lung,1997,175(4):235 -242.
